All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 157 of 206 pages ‹ First < 155 156 157 158 159 > Last ›
HSL2077
Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar;36:(3):216-24
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2923.2002.01140.x
HSL2247
Kunst H, Khan KS.
Quality of web-based medical information on stable COPD: comparison of non-commercial and commercial websites.
Health Info Libr J 2002 Mar;19:(1):42-8
http://www.blackwell-synergy.com/doi/abs/10.1046/j.0265-6647.2001.00363.x
HSL2472
D'Mello B.
Transnational pharmaceutical corporations and neo-liberal business ethics in India.
J Bus Ethics 2002 Mar;36:(1-2):165-85
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12625343
HSL2474
Davidoff F.
Between the lines: Navigating the uncharted territory of industry-sponsored research: A former medical journal editor describes how and why staff changed their policy on disclosing conflicts of interest.
Health Affairs 2002 Mar-Apr;21:(2):235-242
http://www.medscape.com/viewarticle/429526
HSL2480
Cocconi G.
Independent clinical trials: a commentary.
Tumori 2002 Mar-Apr;88:(2):85-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12088263
HSL2489
Brody H.
A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs
Health Affairs (Millwood). 2002 Mar-Apr;21:(2):232-234
http://www.healthaffairs.org/freecontent/s28.htm
HSL6986
de Laat E, Windmeijer F, Douven R
How does pharmaceutical marketing influence doctors' prescribing behaviour?
2002 Mar
http://www.cpb.nl/nl/news/2002_11.html
HSL7759
Newton GD, Benninghoff AJ, Pray WS, Popovich NG.
New OTC drugs and devices 2001: a selective review.
J Am Pharm Assoc (Wash) 2002 Mar-Apr;42:(2):267-77
HSL17917
Background on the Prescription Drug User Fee Act
Patient and Consumer Coalition 2002 Mar
HSL1682
Timmerman L.
Prescription plan becomes a racial issue
Seattle Times business reporter 2002 Feb 27
http://community.seattletimes.nwsource.com/archive/?date=20020227&slug=drughearing270
HSL1683
Johnson E.
Direct-to-consumer advertising
2002 Feb 27
HSL1684
Excepts from advertisements for mobile sales information systems from AvantGo
2002 Feb 27
HSL1681
FDA hits Elan, Pharmacia and Roche on ad practices
FDA news Daily Bulletin 2002 Feb 26
HSL1680
Pallarito K.
Vermont bill would impose fees on drug detailers
Reuters Health 2002 Feb 25
HSL1679
Ross B, Scott DW.
Do Drug Company Perks Influence Doctors? How Pharmaceutical Companies Use Enticement to ‘Educate’ Physicians
ABC News USA 2002 Feb 21
http://abcnews.go.com/Primetime/story?id=132141&page=1
HSL5592
Shann F.
Research in developing countries.
N Engl J Med 2002 Feb 21;346:(8):627-8
HSL1839
Glazer JL.
Pharmaceutical representatives and resident physicians.
JAMA 2002 Feb 20;287:(7):844
http://jama.ama-assn.org/cgi/content/full/287/7/844
HSL1936
Shuchman M.
The Olivieri dispute: no end in sight?
CMAJ 2002 Feb 19;166:(4):487
http://www.cmaj.ca/cgi/content/full/166/4/487, http://www.cmaj.ca/cgi/reprint/166/4/487.pdf
HSL2465
Gibson E, Baylis F, Lewis S.
Dances with the pharmaceutical industry.
CMAJ 2002 Feb 19;166:(4):448-50
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11873922
HSL2679
Questions of interest
Canadian Medical Association Journal 2002 Feb 19;166:(4):413
HSL17980
Naylor CD
Early Toronto experience with new standards for industry-sponsored clinical research: a progress report
CMAJ 2002 Feb 19;166:(4):453
http://www.ecmaj.com/cgi/content/full/166/4/453
HSL1257
Wolfe SM.
Direct-to-consumer advertising--education or emotion promotion?
N Engl J Med 2002 Feb 14;346:(7):524-6
http://content.nejm.org/cgi/content/extract/346/7/524
HSL1676
Drug companies are increasingly targeting patients
Associated Press 2002 Feb 14
HSL1678
Connolly C.
Drug Marketers Focus on Doctors: Consumer Ads Up -- but Still Secondary
Washington Post 2002 Feb 14
www.washingtonpost.com/wp-dyn/articles/A7256-2002Feb13.html
HSL2455
Holmer AF.
Direct-to-consumer advertising--strengthening our health care system.
N Engl J Med 2002 Feb 14;346:(7):526-8
http://content.nejm.org/cgi/content/extract/346/7/526
HSL2471
Drazen JM.
The consumer and the learned intermediary in health care.
N Engl J Med 2002 Feb 14;346:(7):523-4
http://content.nejm.org/cgi/content/full/346/7/523
HSL17981
Lee TH, Brennan TA.
Direct-to-consumer marketing of high-technology screening tests.
N Engl J Med 2002 Feb 14;346:(7):529-31
http://content.nejm.org/cgi/content/extract/346/7/529
HSL1675
Heinzl J.
Drug makers said to skirt Canadian restrictions on ads
Globe and Mail 2002 Feb 12
HSL1677
Neurontin (GABAPENTIN)--The Illegal Corporate Creation of a Blockbuster Drug
Public Citizen 2002 Feb 12
https://www.worstpills.org/login.cfm?redirected=1&page=/member/newsletter.cfm&qString=n_id%3D62
HSL1674
Spencer C.
Everyone gets to know about prescriptions -- except the patient
The Ottawa Citizen 2002 Feb 11
HSL1673
HAI DTCA statement
2002 Feb 10
http://www.haiweb.org/campaign/DTCA/index.html
HSL19524
Katz D
Bioethics on NBC's ER: The Agony and the Ecstasy of Free Lunch
Bioethics.net 2002 Feb 10;
http://bioethics.net/articles.php?viewCat=7&articleId=163
HSL1671
Boseley S.
Scandal of scientists who take money for papers ghostwritten by drug companies: Doctors named as authors may not have seen raw data
The Guardian 2002 Feb 7
HSL1672
Boseley. S
'It said the drug was the best thing since sliced bread. I don't think it is'.
The Guardian. 2002 Feb 7
http://www.guardian.co.uk/uk/2002/feb/07/research.health
HSL1670
Stolberg S.
Study Says Clinical Guides Often Hide Ties of Doctors
New York Times 2002 Feb 6
http://www.nytimes.com/2002/02/06/health/06DRUG.html?pagewanted=1
HSL1669
Direct-to-Consumer Advertising of Pharmaceuticals
2002 Feb 5
HSL2249
Komesaroff PA, Kerridge IH.
Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry
Med J Aust 2002 Feb 4;176:(3):118-21
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11936308
HSL16526
Bamforth I
Knock: a study in medical cynicism
Medical Humanities 2002 Feb 4;28:(1):14
http://mh.bmj.com/cgi/content/full/28/1/14
HSL1667
Mansfield P, Evans A.
Costs are important but it's medicines that save lives
Australian Financial Review 2002 Feb 2
HSL1668
Picard A.
Patients requesting advertised drugs
GLOBE AND MAIL 2002 Feb 2
HSL7762
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion SA.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.
BMJ 2002 Feb 2;324:(7332):278-9
http://www.bmj.com/cgi/content/full/324/7332/278
HSL20088
Brook S
Bones of contention
The Weekend Australia 2002 Feb 224
HSL1665
Jack I.
Majority wants drug ads legalized, poll shows
Financial Post: Canada 2002 Feb 1
HSL1666
68% of Canadians Support Direct to Consumer Advertising for Prescription Medications
Ipsos-Reid 2002 Feb 1
http://www.ipsos-reid.com/media/dsp_displaypr_cdn.cfm?id_to_view=1417
HSL3690
Mintzes B, Barer ML, Kazanjian A, Bassett K, Evans RG, Morgan S.
An assessment of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume I: Executive Summary.
: Centre for Health Services and Policy Research. Date uncertain 2002 Feb 01
http://www.chspr.ubc.ca/hpru/pdf/dtca-v1-execsum.pdf
HSL5289
Barclay S, Todd C, Finlay I, Grande G, Wyatt P.
Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs.
Fam Pract 2002 Feb 01;19:(1):105-11
http://fampra.oxfordjournals.org/cgi/content/full/19/1/105
HSL1664
RiviÈre P.
Drug deals in Europe
Le Monde diplomatique 2002 Feb
http://MondeDiplo.com/2002/02/05drugs
HSL1685
Sandvik H.
Norwegian GPs Protest Withdrawal of Cheap Antihypertensives
Wonca News 2002 Feb
http://www.globalfamilydoctor.com/publications/woncaNews
HSL1931
Studin I.
Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
Manag Care 2002 Feb;11:(2):46,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11904913http://
HSL2150
Mintzes , B. et al.
An assessment of the health system impacts of direct- to-consumer advertising of prescription medicines (DTCA)
Vancouver: Centre for Health Services and Policy research, The University of British Columbia 2002 Feb
http://www.chspr.ubc.ca/hpru/pdf/dtca-v1-execsum.pdf
HSL2461
Haugh R, Thrall TH, Scalise D.
Prescription for concern.
Hosp Health Netw 2002 Feb;76:(2):44-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11912988http://
HSL2496
Berkowitz BA, Sachs G.
Life Cycle of A Block Buster Drug: Discovery and Development of Omeprazole (PrilosecTM)
Mol Interv 2002 Feb;2:(1):6-11
http://molinterv.aspetjournals.org/cgi/content/full/2/1/6, http://molinterv.aspetjournals.org/cgi/reprint/2/1/6,
HSL17982
Cooper R, Hoffman J.
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract 2002 Feb;52:(475):168-9
http://www.ingentaconnect.com/content/rcgp/bjgp/2002/00000052/00000475;jsessionid=1csp69ve6uaku.alexandra?
HSL1662
This is your school on drugs
2002 Jan 31
HSL1663
Rovner J.
Generic Drugs Could Cut Cost of Medicare Benefit
2002 Jan 31
http://story.news.yahoo.com/news?tmpl=story&cid=594&u=/nm/20020131/hl_nm/drugs_2
HSL4525
Website targets DTC ads.
PMLive.com 2002 Jan 31
http://www.pmlive.com/archive.cfm?&ArticleID=4380&back=-1
HSL1661
Harris G.
Merck will be spinning off Merck-Medco.
Wall Street Journal 2002 Jan 29
http://online.wsj.com/article/SB1012254175800950080.html?mod=googlewsj
HSL1658
Zwillicht T.
Congress to Seek $300 Billion for Medicare Benefit
Reuters Health 2002 Jan 28
HSL1660
Page S.
Drug ads: Saving lives, or selling snake oil?
The Ottawa Citizen 2002 Jan 28
HSL1924
Thomas PS, Tan KS, Yates DH.
Sponsorship, authorship, and accountability.
Lancet 2002 Jan 26;359:(9303):351
http://linkinghub.elsevier.com/retrieve/pii/S0140673602075062
HSL1971
Peddicord D; Covance Inc; ICON Clinical Research; Inveresk Research Group; Kendle International, Inc; PAREXEL Internatinal Corporation; PPD Development; Quintiles Transnational Corporation.
Sponsorship, authorship, and accountability.
Lancet 2002 Jan 26;359:(9303):350
http://linkinghub.elsevier.com/retrieve/pii/S0140673602075037
HSL6983
Di GIOVANNA.
Sponsorship, authorship, and accountability (3rd of 5 letters)
The Lancet 2002 Jan 26;359:(350-351):
HSL6984
Kalman C.
Sponsorship, authorship, and accountability (5th of 5 letters)
The Lancet 2002 Jan 26;359:(351-352):
HSL6985
Stonier P, Wells F.
Sponsorship, authorship, and accountability (2nd of 5 letters)
The Lancet 2002 Jan 26;359:(350):
HSL1657
Freudenheim M.
Many H.M.O.'s for the Elderly Make Deep Cuts in Drug Aid
New York Times 2002 Jan 25
http://www.nytimes.com/2002/01/25/business/25CARE.html
HSL1964
Reidenberg MM.
Sponsorship, authorship, and accountability.
N Engl J Med 2002 Jan 24;346:(4):290-2
http://content.nejm.org/cgi/content/extract/346/4/290
HSL6977
Holmer AF.
Sponsorship, authorship, and accountability.
N Engl J Med 2002 Jan 24;346:(4):290-2
HSL6978
International COMMITTEE.
Sponsorship, authorship, and accountability (7th of 7 letters)
New England Journal of Medicine 2002 Jan 24;364:(4):291-292
HSL6979
Landow L.
Sponsorship, authorship, and accountability.
N Engl J Med 2002 Jan 24;346:(4):290-2
HSL6980
Loder E.
Sponsorship, authorship, and accountability.
N Engl J Med 2002 Jan 24;346:(4):290-2
HSL6981
Peddicord D.
Sponsorship, authorship, and accountability (5th of 7 letters)
New England Journal of Medicine 2002 Jan 24;346:(4):291
HSL6982
Relman AS.
Sponsorship, authorship, and accountability.
N Engl J Med 2002 Jan 24;346:(4):290-2
HSL1656
Fraser M.
Drugs, ads and the 'direct' debate: Broadcasters want ability to peddle brand name drugs
Financial Post 2002 Jan 21
HSL1655
Brubaker B.
Drug Firms Still Lavish Pricey Gifts On Doctors Ethics Debated As Freebies Flow
Washington Post 2002 Jan 19
http://www.factsantidepressants.com/Drug-Firms-Still-Lavish-Pricey-Gifts-On-Doctors.htm
HSL1653
Corbey D
Patient doesn’t benefit from direct-to-consumer advertising
Opinion page NRC Handelsblad 2002 Jan 17
HSL17990
Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA.
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.
JAMA 2002 Jan 16;287:(3):337-44
http://jama.ama-assn.org/cgi/content/full/287/3/337
HSL1652
US Docs Opt for Pricey Drugs for Urinary Infection
Reuters Health 2002 Jan 14
HSL1651
Barnes S.
Not a Generic Medicaid Director
New York Times 2002 Jan 13
http://www.nytimes.com/2002/01/13/business/private-sector-not-a-generic-medicaid-director.html?pagewanted=1
HSL17987
Marwick C.
Journal 'should have revealed scientist's connection to company'
BMJ 2002 Jan 12;324:(7329):70
http://www.bmj.com/cgi/content/full/324/7329/70?view=long&pmid=11786448
HSL17988
Josefson D.
Drug companies face pressure on profits.
BMJ 2002 Jan 12;324:(7329):65
http://www.bmj.com/cgi/content/full/324/7329/65?view=long&pmid=11786439
HSL1650
Debate opens on direct-to-consumer drug promotion in Europe
Press Release: Brussels 2002 Jan 11
HSL1569
The Bureau of National Affairs, Inc
Bush Signs Pediatric Incentive Bill Extending Exclusivity Provision Until 2007
2002 Jan 9
HSL1567
Petersen M.
Pfizer's Chief Is Subpoenaed in an Inquiry on Drug Pricing
New York Times 2002 Jan 8
http://www.nytimes.com/2002/01/08/business/08DRUG.html
HSL1568
FTC Questions Patent Listings on Brand-Name Prescription Drugs
Kaiser Daily Health Policy Report 2002 Jan 8
HSL17983
Laupacis A.
Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
CMAJ 2002 Jan 8;166:(1):44-7
http://www.cmaj.ca/cgi/content/full/166/1/44
HSL1566
Davis A.
'Postmarketing' by Makers of Alzheimer's Pill Raises Questions About the Uses of Research
The Wall Street Journal 2002 Jan 7
http://online.wsj.com/article/SB1010364361294762440.html?mod=googlewsj
HSL17391
Silverman E
Acne drug article under fire Link between author, company is criticized
The Star Ledger 2002 Jan 6
HSL17984
Sharma R
WHO calls for closer monitoring of commercial interests
BMJ 2002 Jan 5;324:(7328):8
http://www.bmj.com/cgi/content/extract/324/7328/8/b
HSL1565
Gold R.
Federal Judge Lets Stand Florida Law Seeking Rebates From Drug Makers
The Wall Street Journal 2002 Jan 3
http://online.wsj.com/article/SB1010008142877430440.html?mod=googlewsj
HSL1982
Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O'Bannon JM 3rd, Goldrich MS, Ray P, Weiss M, Sade RM, Spillman MA.
Managing conflicts of interest in the conduct of clinical trials.
JAMA 2002 Jan 2;287:(1):78-84
http://jama.ama-assn.org/cgi/content/full/287/1/78
HSL17986
Gelijns AC, Thier SO.
Medical innovation and institutional interdependence: rethinking university-industry connections.
JAMA 2002 Jan 2;287:(1):72-7
http://jama.ama-assn.org/cgi/content/full/287/1/72
HSL17989
Tsai AC
Free Software and Physician Profiling
JAMA 2002 Jan 2;287:(1):45
http://jama.ama-assn.org/cgi/content/extract/287/1/45
HSL1256
Zachry WM 3rd, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA.
Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.
Am J Health Syst Pharm 2002 Jan 1;59:(1):42-9
http://www.ajhp.org/cgi/reprint/59/1/42
HSL7799
Young D.
Studies show drug ads influence prescription decisions, drug costs.
Am J Health Syst Pharm 2002 Jan 1;59:(1):14,
http://www.ajhp.org/cgi/reprint/59/1/14
HSL7800
Young D.
States form coalitions to leverage lower prescription drug prices.
Am J Health Syst Pharm 2002 Jan 1;59:(1):20-1
http://www.ajhp.org/cgi/pmidlookup?view=reprint&pmid=11813461
HSL7817
Zachry WM 3rd, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA.
Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.
Am J Health Syst Pharm 2002 Jan 1;59:(1):42-9
http://www.ajhp.org/cgi/reprint/59/1/42
HSL1563
National Health.
Direct-To-Consumer Prescription Drug Advertising
2002 Jan
http://www.nationalhealthcouncil.org/advocacy/dtc_paper.htm
HSL1564
Norris P.
Talking the Talk
Prescriber Update 2002 Jan
HSL1840
Wolfe SM.
The destruction of medicine by market forces: teaching acquiescence or resistance and change?
Acad Med 2002 Jan;77:(1):5-7
http://www.academicmedicine.org/cgi/content/full/77/1/5
HSL1930
Sumpradit N, Fors SW, McCormick L.
Consumers' attitudes and behavior toward prescription drug advertising.
Am J Health Behav 2002 Jan-Feb;26:(1):68-75
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11795607
Page 157 of 206 pages ‹ First < 155 156 157 158 159 > Last ›
